Octapharma USA, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$17.6M
Doctors Paid
7,638
Transactions
23,074
2024 Total
$1.8M
Payment Breakdown by Category
Research$13.7M (77.8%)
Travel$651,481 (3.7%)
Food & Beverage$622,832 (3.5%)
Consulting$140,954 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $13.7M | 1,888 | 77.8% |
| Honoraria | $1.2M | 434 | 6.6% |
| Grant | $885,287 | 10 | 5.0% |
| Travel and Lodging | $651,481 | 1,239 | 3.7% |
| Food and Beverage | $622,832 | 19,300 | 3.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $437,220 | 15 | 2.5% |
| Consulting Fee | $140,954 | 154 | 0.8% |
| Education | $3,150 | 34 | 0.0% |
Payments by Type
Research
$13.7M
1,888 transactions
General
$3.9M
21,186 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Von Willebrand Factor in Pregnancy (VIP) Study | $2.0M | 0 | 2 |
| GAM10-10 | $1.2M | 3 | 67 |
| NGAM-13 | $1.2M | 8 | 106 |
| INdividualized ITI based on fviii ATE protection by vwf INITIATE | $1.1M | 0 | 1 |
| GAM5-28 | $1.0M | 2 | 331 |
| LEX-211 | $1.0M | 4 | 30 |
| GAM10-08 | $880,249 | 8 | 204 |
| SCGAM-06 | $683,480 | 7 | 178 |
| LEX-209 | $452,610 | 11 | 196 |
| NORM-01 | $383,258 | 1 | 70 |
| NGAM-12 | $348,562 | 4 | 117 |
| LEX-210 | $329,999 | 1 | 35 |
| Von Willebrand Factor in Pregnancy | $329,662 | 0 | 8 |
| SCGAM-03 | $319,159 | 4 | 51 |
| NGAM-10 | $241,150 | 3 | 77 |
| SCGAM-01 | $193,594 | 0 | 32 |
| LAS-215 | $176,936 | 3 | 31 |
| LAS-213 | $161,157 | 5 | 45 |
| CUTAQUIG REGISTRY | $151,582 | 0 | 3 |
| Gena-21b | $120,638 | 0 | 45 |
| Cutaquig Registry | $119,129 | 0 | 1 |
| Gena-05 | $118,264 | 0 | 29 |
| PPH STUDY | $114,955 | 0 | 3 |
| ATN-106 | $105,448 | 1 | 9 |
| GENA-21b | $102,902 | 0 | 16 |
| LAS-212 | $86,005 | 4 | 24 |
| PANS STUDY | $81,078 | 0 | 2 |
| NGAM-11 | $67,223 | 7 | 18 |
| OCTAPLAS IIS STUDY | $62,165 | 0 | 4 |
| GENA-05 | $52,387 | 5 | 30 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Isaac Melamed, M.d, M.D | Specialist | Centennial, CO | $163,330 | $0 |
| Dr. Rohit Aggarwal, M.d, M.D | Rheumatology | Pittsburgh, PA | $156,111 | $0 |
| Lawrence Steinman, Md, MD | Neurology | Palo Alto, CA | $114,105 | $0 |
| Robert Sidonio, Md, MD | Pediatric Hematology-Oncology | Atlanta, GA | $108,783 | $0 |
| Dr. Kyle Williams, M.d, M.D | Student in an Organized Health Care Education/Training Program | Boston, MA | $104,982 | $0 |
| Jennifer Frankovich, Md, MD | Pediatrics | Palo Alto, CA | $99,067 | $0 |
| Mazen Dimachkie, M.d, M.D | Neuromuscular Medicine | Kansas City, KS | $81,589 | $0 |
| Fernando Corrales Medina, Md, MD | Pediatrics | Miami, FL | $70,245 | $0 |
| Mr. Roger Kobayashi, M.d, M.D | Allergy & Immunology | Omaha, NE | $62,541 | $0 |
| Dr. Guy Young, M.d, M.D | Pediatric Hematology-Oncology | Bozeman, MT | $57,713 | $0 |
| Dr. Jill Johnsen, Md, MD | Hematology & Oncology | Seattle, WA | $54,776 | $0 |
| Mr. Michael Daines, M.d, M.D | Allergy & Immunology | Tucson, AZ | $52,777 | $0 |
| Craig Kessler | Hematology & Oncology | Washington, DC | $52,464 | $0 |
| Dr. Daniel Katz, M.d, M.D | Anesthesiology | New York, NY | $49,797 | $0 |
| Sudhir Gupta, Md, MD | Adolescent Medicine | Irvine, CA | $48,647 | $0 |
| Dr. Ravindra Sarode, Md, MD | Blood Banking & Transfusion Medicine | Dallas, TX | $45,908 | $0 |
| Kenichi Tanaka, M.d, M.D | Anesthesiology | Oklahoma City, OK | $43,583 | $0 |
| Dr. Melissa Cushing, M.d, M.D | Clinical Pathology/Laboratory Medicine | New York, NY | $43,152 | $0 |
| Allison Wheeler, M.d, M.D | Pediatrics | Seattle, WA | $42,287 | $0 |
| Hing-Sheung Fung, Md, MD | Rheumatology | Waco, TX | $41,148 | $0 |
| Dr. Ai Lan Kobayashi, M.d, M.D | Pediatrics | Papillion, NE | $40,710 | $0 |
| Dr. Frank Sellke, Md, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Providence, RI | $33,514 | $0 |
| John Wright, Md, MD | Surgery | Nashville, TN | $33,496 | $0 |
| Lisa Boggio, Md, MD | Hematology & Oncology | Chicago, IL | $32,952 | $0 |
| Dr. Jonathan Ducore, Md, Mph, MD, MPH | Pediatric Hematology-Oncology | Sacramento, CA | $31,072 | $0 |
Ad
Top Products
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) $2.9M
- OCTAGAM IMMUNE GLOBULIN (HUMAN) $2.4M
Associated Products (14)
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) $2.9M
- OCTAGAM IMMUNE GLOBULIN (HUMAN) $2.8M
- PANZYGA $2.5M
- WILATE $2.0M
- CUTAQUIG $1.6M
- OCTAGAM $1.4M
- NUWIQ $1.1M
- OCTAPLAS $560,635
- FIBRYGA $418,333
- OCTAPLEX $400,900
- OCTANORM $341,872
- CUTAQUIQ $82,876
- BALFAXAR $49,885
- IVIG $29,114
Payment Categories
- Food & Beverage $622,832
- Consulting $140,954
- Travel & Lodging $651,481
- Research $13.7M
About Octapharma USA, Inc.
Octapharma USA, Inc. has made $17.6M in payments to 7,638 healthcare providers, recorded across 23,074 transactions in the CMS Open Payments database. In 2024, the company paid $1.8M. The top product by payment volume is WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) ($2.9M).
Payments were distributed across 166 medical specialties. The top specialty by payment amount is Pediatric Hematology-Oncology ($603,018 to 125 doctors).
Payment categories include: Food & Beverage ($622,832), Consulting ($140,954), Research ($13.7M), Travel & Lodging ($651,481).
Octapharma USA, Inc. is associated with 14 products in the CMS Open Payments database, including WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN), OCTAGAM IMMUNE GLOBULIN (HUMAN), and PANZYGA.